Latest Period
Q4 2025
Security Snapshot
Enveric Biosciences, Inc. - Common Stock, $0.01 par value (ENVB) Institutional Ownership
CUSIP: 29405E505
13F Institutional Holders and Ownership History for Q4 2025
Institutions Reporting
11
Shares (Excl. Options)
24,171
Price
$3.63
- Type / Class
- Equity / Common Stock, $0.01 par value
- Symbol
- ENVB on Nasdaq
- Shares outstanding
- 1,414,064
- Price per share
- $1.97
- All holders as of 31 Dec 2025
- Q4 2025
- Total 13F shares
- 24,171
- Total reported value
- $87,744
- % of total 13F portfolios
- 0%
- Share change
- +24,171
- Value change
- +$87,744
- Number of holders
- 11
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Quick Takeaways
- ENVB - Enveric Biosciences, Inc. - Common Stock, $0.01 par value is tracked under CUSIP 29405E505.
- 11 institutions reported positions in Q4 2025.
- 3 significant owners is listed from Schedule 13D/13G reporting.
What Changed
- Latest quarter on this page is Q4 2025.
- Additional quarter-over-quarter change detail appears as history expands.
Why This Matters
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Official SEC Source
Backed by Form 13F
Ownership context comes from SEC Form 13F and, when available, Schedule 13D/13G filings.
See Original FilingInvestment Quick Answers
What is CUSIP 29405E505?
CUSIP 29405E505 identifies ENVB - Enveric Biosciences, Inc. - Common Stock, $0.01 par value in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.
Continue Investment Research
- Latest 13F filings for new institutional portfolio disclosures.
- Latest Schedule 13D/13G reports for activist and beneficial ownership updates.
- Latest 10-Q/10-K reports to cross-check issuer fundamentals.
- Recent insider transactions for management buying/selling context.
- SEC investors directory and top value investors for manager-level discovery.
- All institutional ownership pages to compare adjacent CUSIP pages.
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 29405E505:
Significant Owners of Enveric Biosciences, Inc. - Common Stock, $0.01 par value (ENVB) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Ayrton Capital LLC | 10% | 658,465 | Ayrton Capital LLC | 30 Sep 2025 | ||||
| Lind Global Fund III LP | 10% | $552,346 | 141,265 | Lind Global Fund III LP | 28 Jan 2026 | |||
| INTRACOASTAL CAPITAL, LLC | 5% | 0% | $278,572 | +$155,982 | 71,246 | +127% | Mitchell P. Kopin | 27 Jan 2026 |
As of 31 Dec 2025, 11 institutional investors reported holding 24,171 shares of Enveric Biosciences, Inc. - Common Stock, $0.01 par value (ENVB). This represents 1.7% of the company’s total 1,414,064 outstanding shares.
Institutional Holders of Enveric Biosciences, Inc. - Common Stock, $0.01 par value (ENVB) across Reporting Periods
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 24,171 | $87,744 | +$87,744 | $3.63 | 11 |